secwatch / observer
8-K filed August 11, 2023, 7:59 PM ET ticker ANNA CIK 0001845123
M&A confidence high sentiment positive materiality 0.90

Swiftmerge Acquisition Corp. announces $400M merger with HDL Therapeutics

AleAnna, Inc.

Key facts

Extracted from this filing and checked against the source text.

Material Agreements SEC 8-K Item 1.01/1.02 confidence 0.9

AleAnna, Inc. entered into Merger Agreement with HDL Therapeutics, Inc. and IVCP Merger Sub, Inc. valued at $400,000,000 (effective 2023-08-11).

Action
entry
Agreement
merger
Counterparty
HDL Therapeutics, Inc. and IVCP Merger Sub, Inc.
Value
$400,000,000
Effective
2023-08-11
Exact text from the filing
On August 11, 2023, Swiftmerge entered into a Merger Agreement (the “ Merger Agreement ”) with HDL Therapeutics, Inc., a Delaware corporation (“ HDL ”), and IVCP Merger Sub, Inc., a Delaware corporation and a direct wholly owned subsidiary of Swiftmerge (“ Merger Sub ” and, together with Swiftmerge and HDL the “ Parties ”). Capitalized terms used in this Current Report on Form 8-K but not otherwise defined herein have the meanings given to them in the Merger Agreement. The Merger The Merger Agreement provides that, among other things and upon the terms and subject to the conditions thereof, the following transactions will occur (together with the other agreements and transactions contemplated by the Merger Agreement, the “ Business Combination ”): (i) at the closing of the transactions contemplated by the Merger Agreement (the “ Closing ”), upon the terms and subject to the conditions of the Merger Agreement, in accordance with the General Corporation Law of the State of Delaware, as a
View on SEC.gov

Browse all material agreements →

AleAnna, Inc. filing history →

Source: SEC EDGAR
accession 0001193125-23-210882
Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.